A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Clinical trial NCT06592586 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06592586
Sponsor: Minervax ApS
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Streptococcus Agalactiae Infection Neonatal Sepsis Pneumonia Meningitis Neonatal Infection Gram-Positive Bacterial Infections Bacterial Infections Bacterial Infections and Mycoses Infections

Start date: 2025-03-07
Primary completion: 2029-06-30
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.